Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis.

Koch, Jan C; Kuttler, Josua; Maass, Fabian; Lengenfeld, Teresa; Zielke, Eirini; Bähr, Mathias; Lingor, Paul

Koch, Jan C; Kuttler, Josua; Maass, Fabian; Lengenfeld, Teresa; Zielke, Eirini; Bähr, Mathias; Lingor, Paul.

Afiliación

Koch JC; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Kuttler J; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Maass F; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Lengenfeld T; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Zielke E; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Bähr M; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Lingor P; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.

Front Neurol ; 11: 173, 2020.

Article en En | MEDLINE | ID: mdl-32231638

Palabras clave

Fasudil; ROCK inhibition; Rho kinase; SOD1; amyotrophic lateral sclerosis; compassionate use; therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Neurol Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google